Eurofins Analytik GmbH in Germany appointed as GAFTA referee laboratory
Hamburg/Bremen, January 17, 2008
Eurofins is glad to announce that its Wiertz-Eggert-Jörissen laboratory in Bremen has been nominated as the only German GAFTA referee laboratory under Rule No. 124 as of January 1st 2008. Eurofins | Wiertz-Eggert-Jörissen shares this status with eight laboratories in seven further countries, among these Eurofins | Steins in Denmark.
Since 1878 the Grain and Feed Trade Association (GAFTA) in London has been promoting international trade and works to protect the interests of its members including traders of grain, animal feedstuffs, pulses and rice. Products are traded under standardised GAFTA terms and conditions, among them Rule No. 124 covering the quality control of shipments by setting down sampling and analysis requirements.
“We thank GAFTA for the nomination and are glad for this opportunity to serve its members. Our laboratory in Bremen is close to the major ports in Hamburg, Bremerhaven, Bremen and Brake which is very convenient for the German importers of grain and feedstuff“, said Dr. Werner Nader, Marketing and Sales Manager of Eurofins’ food and feed division in Germany.
Dr. Chris Würdemann, head of the W.E.J. Bremen site, continued: “The fact that two Eurofins laboratories, Steins and Wiertz-Eggert-Jörissen, are now GAFTA referee laboratories, will be of substantial benefit to the traders both in Germany and in Scandinavia. We will continue to collaborate closely with our Scandinavian colleagues to improve our services on a European level.”
For further information about Eurofins please visit www.eurofins.com or contact:
Dr. Werner Nader
Eurofins Analytik GmbH
Neuländer Kamp 1
D-21079 Hamburg
Email: wernernader@eurofins.de
Dr. Chris Würdemann
Eurofins Analytik GmbH
Fahrenheitstr. 1
D-28359 Bremen
Email: chriswuerdemann@eurofins.de
-
-
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific is a life sciences company operating internationally to provide a comprehensive range of analytical testing services to clients from a wide range of industries including the pharmaceutical, food and environmental sectors.
With over 7,000 staff in more than 100 laboratories across 29 countries, Eurofins offers a portfolio of over 25,000 reliable analytical methods for evaluating the authenticity, origin, safety, identity, composition and purity of biological substances and products. The Group is committed to provide its customers with high quality services, accurate results in time and, if requested, expert advice by our highly qualified staff.
The Eurofins Group is one of the global market leaders in this field of applied life sciences. It intends to pursue its dynamic growth strategy and expand both, its technology portfolio and its geographic reach. Through R&D, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international player in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on Euronext in the Paris (ISIN FR0000038259) and Frankfurt (WKN 910251) Stock Exchanges (Reuters EUFI.LN, Bloomberg ERF FP, ESF, EUFI.DE).